Adolescent and young adult (AYA) patients with cancer have not seen the same improvements in survival over the years as their pediatric and older adult counterparts. Some evidence has suggested […]
Reacting to public criticism of the U.S. Food and Drug Administration’s (FDA’s) accelerated approval of Alzheimer’s disease treatment Aduhelm, the U.S. Department of Health and Human Services (HHS) recently announced […]
Not many three-year-olds have attained such an impressive pedigree, but the All of Us Research Program from the National Institutes of Health (NIH) is marking its latest birthday […]
While the COVID-19 pandemic has splashed clinical trials news across the front pages and atop the nightly news for more than a year, the workforce remains something of a “hidden […]
Cancer clinical trial research rapidly adapted to the circumstances of enrolling and treating patients on clinical trials during the COVID-19 pandemic. That’s the conclusion drawn by authors of a study […]